Barclays
CC icon

Barclays’s Chemours CC Stock Holding History

Barclays’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-85,000
Closed -$2.6M – 5113
2022
Q4 		$2.6M Buy
+85,000
New +$2.55M ﹤0.01% 2071
2022
Q1 		– Sell
-315,300
Closed -$10.6M – 4999
2021
Q4 		$10.6M Buy
315,300
+40,300
+15% +$1.26M ﹤0.01% 1238
2021
Q3 		$7.99M Buy
275,000
+75,000
+38% +$2.43M ﹤0.01% 1323
2021
Q2 		$6.96M Buy
+200,000
New +$6.62M ﹤0.01% 1399
2021
Q1 		– Sell
-1,000
Closed -$25K – 4734
2020
Q4 		$25K Buy
+1,000
New +$23.8K ﹤0.01% 4629
2020
Q3 		– Sell
-123,500
Closed -$1.9M – 5239
2020
Q2 		$1.9M Sell
123,500
-2,500
-2% -$31.6K ﹤0.01% 2170
2020
Q1 		$1.12M Sell
126,000
-302,100
-71% -$4.36M ﹤0.01% 2835
2019
Q4 		$7.74M Sell
428,100
-116,200
-21% -$1.93M ﹤0.01% 1589
2019
Q3 		$8.13M Buy
544,300
+356,900
+190% +$5.81M 0.01% 1455
2019
Q2 		$4.5M Buy
+187,400
New +$5.52M ﹤0.01% 1969
2019
Q1 		– Sell
-51,300
Closed -$1.45M – 7031
2018
Q4 		$1.45M Buy
51,300
+30,100
+142% +$952K ﹤0.01% 2738
2018
Q3 		$836K Buy
21,200
+14,400
+212% +$630K ﹤0.01% 3808
2018
Q2 		$301K Buy
6,800
+5,400
+386% +$269K ﹤0.01% 4375
2018
Q1 		$68K Buy
1,400
+300
+27% +$15K ﹤0.01% 5650
2017
Q4 		$55K Sell
1,100
-4,800
-81% -$251K ﹤0.01% 5693
2017
Q3 		$299K Sell
5,900
-700
-11% -$33K ﹤0.01% 4077
2017
Q2 		$250K Buy
6,600
+4,500
+214% +$178K ﹤0.01% 4174
2017
Q1 		$81K Sell
2,100
-96,580
-98% -$2.91M ﹤0.01% 5038
2016
Q4 		$2.18M Buy
98,680
+92,700
+1,550% +$1.9M ﹤0.01% 2051
2016
Q3 		$96K Hold
5,980
– – ﹤0.01% 4534
2016
Q2 		$49K Hold
5,980
– – ﹤0.01% 4836
2016
Q1 		$42K Sell
5,980
-35,580
-86% -$179K ﹤0.01% 4870
2015
Q4 		$208K Sell
41,560
-18,240
-31% -$117K ﹤0.01% 3877
2015
Q3 		$358K Buy
+59,800
New +$626K ﹤0.01% 3653

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's CC Position: Q1 2026 in Review

Barclays reduced its Chemours (CC) stake by 86% in Q1 2026, selling an estimated $3.52M and leaving 32,956 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #2954.

Barclays first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $14.8M in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Barclays held 32,956 shares of Chemours worth $726K as of Q1 2026.
  • Barclays sold 202,000 Chemours shares in Q1 2026, an estimated $3.52M.
  • Chemours made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2954 holding.
  • Barclays first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Barclays's Chemours position peaked at $14.8M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.